Global Tofacitinib Citrate API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 111

Published Date: 04 Aug 2022

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Tofacitinib Citrate API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Tofacitinib Citrate API market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Tofacitinib Citrate API market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Tablets occupied for % of the Tofacitinib Citrate API global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, 0.98 segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Tofacitinib Citrate API include Huateng Pharma, Beijing Mesochem Technology, CR Double-Crane Pharmaceuticals, Changzhou Pharmaceutical Factory and Chongqing Fuan Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Tofacitinib Citrate API market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main Tofacitinib Citrate API manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Tofacitinib Citrate API market based on the following parameters – headquarters, production locations, products portfolio, Tofacitinib Citrate API revenue, sales, average price and gross margin, recent developments.

Evaluation and forecast the Tofacitinib Citrate API market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
Tofacitinib Citrate API market is split by Purity and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Purity (2017-2028; USD Million)
    0.98
    0.99
    Others

Market segment by Application (2017-2028; USD Million)
    Tablets
    Others

The key market players for global Tofacitinib Citrate API market are listed below:
    Huateng Pharma
    Beijing Mesochem Technology
    CR Double-Crane Pharmaceuticals
    Changzhou Pharmaceutical Factory
    Chongqing Fuan Pharmaceutical
    Sichuan Renan Pharmaceutical
    Metrochem API
    Dr. Reddy's Laboratories
    Kekule Pharma
    Apotex Pharmachem
    Bulat Pharmaceutical
    Delmar Chemicals
    Glenmark Pharmaceuticals
    Kukjeon Pharmaceutical
    MSN Laboratories
    Mylan Inc
    Vitalpharms

Region Segment (2017-2028; USD Million)
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tofacitinib Citrate API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tofacitinib Citrate API, with price, sales, revenue and global market share of Tofacitinib Citrate API from 2019 to 2022.
Chapter 3, the Tofacitinib Citrate API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tofacitinib Citrate API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Purity and application, with sales market share and growth rate by purity, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tofacitinib Citrate API market forecast, by regions, purity and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tofacitinib Citrate API.
Chapter 13, 14, and 15, to describe Tofacitinib Citrate API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Tofacitinib Citrate API Introduction
    1.2 Market Analysis by Purity
        1.2.1 Overview: Global Tofacitinib Citrate API Revenue by Purity: 2017 Versus 2021 Versus 2028
        1.2.2 0.98
        1.2.3 0.99
        1.2.4 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Tofacitinib Citrate API Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Tablets
        1.3.3 Others
    1.4 Global Tofacitinib Citrate API Market Size & Forecast
        1.4.1 Global Tofacitinib Citrate API Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Tofacitinib Citrate API Sales in Volume (2017-2028)
        1.4.3 Global Tofacitinib Citrate API Price (2017-2028)
    1.5 Global Tofacitinib Citrate API Production Capacity Analysis
        1.5.1 Global Tofacitinib Citrate API Total Production Capacity (2017-2028)
        1.5.2 Global Tofacitinib Citrate API Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Tofacitinib Citrate API Market Drivers
        1.6.2 Tofacitinib Citrate API Market Restraints
        1.6.3 Tofacitinib Citrate API Trends Analysis

2 Manufacturers Profiles
    2.1 Huateng Pharma
        2.1.1 Huateng Pharma Details
        2.1.2 Huateng Pharma Major Business
        2.1.3 Huateng Pharma Tofacitinib Citrate API Product and Services
        2.1.4 Huateng Pharma Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Beijing Mesochem Technology
        2.2.1 Beijing Mesochem Technology Details
        2.2.2 Beijing Mesochem Technology Major Business
        2.2.3 Beijing Mesochem Technology Tofacitinib Citrate API Product and Services
        2.2.4 Beijing Mesochem Technology Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 CR Double-Crane Pharmaceuticals
        2.3.1 CR Double-Crane Pharmaceuticals Details
        2.3.2 CR Double-Crane Pharmaceuticals Major Business
        2.3.3 CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Product and Services
        2.3.4 CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Changzhou Pharmaceutical Factory
        2.4.1 Changzhou Pharmaceutical Factory Details
        2.4.2 Changzhou Pharmaceutical Factory Major Business
        2.4.3 Changzhou Pharmaceutical Factory Tofacitinib Citrate API Product and Services
        2.4.4 Changzhou Pharmaceutical Factory Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Chongqing Fuan Pharmaceutical
        2.5.1 Chongqing Fuan Pharmaceutical Details
        2.5.2 Chongqing Fuan Pharmaceutical Major Business
        2.5.3 Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Product and Services
        2.5.4 Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Sichuan Renan Pharmaceutical
        2.6.1 Sichuan Renan Pharmaceutical Details
        2.6.2 Sichuan Renan Pharmaceutical Major Business
        2.6.3 Sichuan Renan Pharmaceutical Tofacitinib Citrate API Product and Services
        2.6.4 Sichuan Renan Pharmaceutical Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Metrochem API
        2.7.1 Metrochem API Details
        2.7.2 Metrochem API Major Business
        2.7.3 Metrochem API Tofacitinib Citrate API Product and Services
        2.7.4 Metrochem API Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Dr. Reddy's Laboratories
        2.8.1 Dr. Reddy's Laboratories Details
        2.8.2 Dr. Reddy's Laboratories Major Business
        2.8.3 Dr. Reddy's Laboratories Tofacitinib Citrate API Product and Services
        2.8.4 Dr. Reddy's Laboratories Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Kekule Pharma
        2.9.1 Kekule Pharma Details
        2.9.2 Kekule Pharma Major Business
        2.9.3 Kekule Pharma Tofacitinib Citrate API Product and Services
        2.9.4 Kekule Pharma Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Apotex Pharmachem
        2.10.1 Apotex Pharmachem Details
        2.10.2 Apotex Pharmachem Major Business
        2.10.3 Apotex Pharmachem Tofacitinib Citrate API Product and Services
        2.10.4 Apotex Pharmachem Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Bulat Pharmaceutical
        2.11.1 Bulat Pharmaceutical Details
        2.11.2 Bulat Pharmaceutical Major Business
        2.11.3 Bulat Pharmaceutical Tofacitinib Citrate API Product and Services
        2.11.4 Bulat Pharmaceutical Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Delmar Chemicals
        2.12.1 Delmar Chemicals Details
        2.12.2 Delmar Chemicals Major Business
        2.12.3 Delmar Chemicals Tofacitinib Citrate API Product and Services
        2.12.4 Delmar Chemicals Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Glenmark Pharmaceuticals
        2.13.1 Glenmark Pharmaceuticals Details
        2.13.2 Glenmark Pharmaceuticals Major Business
        2.13.3 Glenmark Pharmaceuticals Tofacitinib Citrate API Product and Services
        2.13.4 Glenmark Pharmaceuticals Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Kukjeon Pharmaceutical
        2.14.1 Kukjeon Pharmaceutical Details
        2.14.2 Kukjeon Pharmaceutical Major Business
        2.14.3 Kukjeon Pharmaceutical Tofacitinib Citrate API Product and Services
        2.14.4 Kukjeon Pharmaceutical Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 MSN Laboratories
        2.15.1 MSN Laboratories Details
        2.15.2 MSN Laboratories Major Business
        2.15.3 MSN Laboratories Tofacitinib Citrate API Product and Services
        2.15.4 MSN Laboratories Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Mylan Inc
        2.16.1 Mylan Inc Details
        2.16.2 Mylan Inc Major Business
        2.16.3 Mylan Inc Tofacitinib Citrate API Product and Services
        2.16.4 Mylan Inc Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Vitalpharms
        2.17.1 Vitalpharms Details
        2.17.2 Vitalpharms Major Business
        2.17.3 Vitalpharms Tofacitinib Citrate API Product and Services
        2.17.4 Vitalpharms Tofacitinib Citrate API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Tofacitinib Citrate API Breakdown Data by Manufacturer
    3.1 Global Tofacitinib Citrate API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Tofacitinib Citrate API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Tofacitinib Citrate API
    3.4 Market Concentration Rate
        3.4.1 Top 3 Tofacitinib Citrate API Manufacturer Market Share in 2021
        3.4.2 Top 6 Tofacitinib Citrate API Manufacturer Market Share in 2021
    3.5 Global Tofacitinib Citrate API Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Tofacitinib Citrate API Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Tofacitinib Citrate API Market Size by Region
        4.1.1 Global Tofacitinib Citrate API Sales in Volume by Region (2017-2028)
        4.1.2 Global Tofacitinib Citrate API Revenue by Region (2017-2028)
    4.2 North America Tofacitinib Citrate API Revenue (2017-2028)
    4.3 Europe Tofacitinib Citrate API Revenue (2017-2028)
    4.4 Asia-Pacific Tofacitinib Citrate API Revenue (2017-2028)
    4.5 South America Tofacitinib Citrate API Revenue (2017-2028)
    4.6 Middle East and Africa Tofacitinib Citrate API Revenue (2017-2028)

5 Market Segment by Purity
    5.1 Global Tofacitinib Citrate API Sales in Volume by Purity (2017-2028)
    5.2 Global Tofacitinib Citrate API Revenue by Purity (2017-2028)
    5.3 Global Tofacitinib Citrate API Price by Purity (2017-2028)

6 Market Segment by Application
    6.1 Global Tofacitinib Citrate API Sales in Volume by Application (2017-2028)
    6.2 Global Tofacitinib Citrate API Revenue by Application (2017-2028)
    6.3 Global Tofacitinib Citrate API Price by Application (2017-2028)

7 North America by Country, by Purity, and by Application
    7.1 North America Tofacitinib Citrate API Sales by Purity (2017-2028)
    7.2 North America Tofacitinib Citrate API Sales by Application (2017-2028)
    7.3 North America Tofacitinib Citrate API Market Size by Country
        7.3.1 North America Tofacitinib Citrate API Sales in Volume by Country (2017-2028)
        7.3.2 North America Tofacitinib Citrate API Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Purity, and by Application
    8.1 Europe Tofacitinib Citrate API Sales by Purity (2017-2028)
    8.2 Europe Tofacitinib Citrate API Sales by Application (2017-2028)
    8.3 Europe Tofacitinib Citrate API Market Size by Country
        8.3.1 Europe Tofacitinib Citrate API Sales in Volume by Country (2017-2028)
        8.3.2 Europe Tofacitinib Citrate API Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Purity, and by Application
    9.1 Asia-Pacific Tofacitinib Citrate API Sales by Purity (2017-2028)
    9.2 Asia-Pacific Tofacitinib Citrate API Sales by Application (2017-2028)
    9.3 Asia-Pacific Tofacitinib Citrate API Market Size by Region
        9.3.1 Asia-Pacific Tofacitinib Citrate API Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Tofacitinib Citrate API Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Purity, and by Application
    10.1 South America Tofacitinib Citrate API Sales by Purity (2017-2028)
    10.2 South America Tofacitinib Citrate API Sales by Application (2017-2028)
    10.3 South America Tofacitinib Citrate API Market Size by Country
        10.3.1 South America Tofacitinib Citrate API Sales in Volume by Country (2017-2028)
        10.3.2 South America Tofacitinib Citrate API Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Purity, and by Application
    11.1 Middle East & Africa Tofacitinib Citrate API Sales by Purity (2017-2028)
    11.2 Middle East & Africa Tofacitinib Citrate API Sales by Application (2017-2028)
    11.3 Middle East & Africa Tofacitinib Citrate API Market Size by Country
        11.3.1 Middle East & Africa Tofacitinib Citrate API Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Tofacitinib Citrate API Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Tofacitinib Citrate API and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Tofacitinib Citrate API
    12.3 Tofacitinib Citrate API Production Process
    12.4 Tofacitinib Citrate API Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Tofacitinib Citrate API Typical Distributors
    13.3 Tofacitinib Citrate API Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Tofacitinib Citrate API Revenue by Purity, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Tofacitinib Citrate API Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Huateng Pharma Basic Information, Manufacturing Base and Competitors
    Table 4. Huateng Pharma Major Business
    Table 5. Huateng Pharma Tofacitinib Citrate API Product and Services
    Table 6. Huateng Pharma Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Beijing Mesochem Technology Basic Information, Manufacturing Base and Competitors
    Table 8. Beijing Mesochem Technology Major Business
    Table 9. Beijing Mesochem Technology Tofacitinib Citrate API Product and Services
    Table 10. Beijing Mesochem Technology Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. CR Double-Crane Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 12. CR Double-Crane Pharmaceuticals Major Business
    Table 13. CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Product and Services
    Table 14. CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Changzhou Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
    Table 16. Changzhou Pharmaceutical Factory Major Business
    Table 17. Changzhou Pharmaceutical Factory Tofacitinib Citrate API Product and Services
    Table 18. Changzhou Pharmaceutical Factory Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Chongqing Fuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 20. Chongqing Fuan Pharmaceutical Major Business
    Table 21. Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Product and Services
    Table 22. Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Sichuan Renan Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 24. Sichuan Renan Pharmaceutical Major Business
    Table 25. Sichuan Renan Pharmaceutical Tofacitinib Citrate API Product and Services
    Table 26. Sichuan Renan Pharmaceutical Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Metrochem API Basic Information, Manufacturing Base and Competitors
    Table 28. Metrochem API Major Business
    Table 29. Metrochem API Tofacitinib Citrate API Product and Services
    Table 30. Metrochem API Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
    Table 32. Dr. Reddy's Laboratories Major Business
    Table 33. Dr. Reddy's Laboratories Tofacitinib Citrate API Product and Services
    Table 34. Dr. Reddy's Laboratories Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Kekule Pharma Basic Information, Manufacturing Base and Competitors
    Table 36. Kekule Pharma Major Business
    Table 37. Kekule Pharma Tofacitinib Citrate API Product and Services
    Table 38. Kekule Pharma Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Apotex Pharmachem Basic Information, Manufacturing Base and Competitors
    Table 40. Apotex Pharmachem Major Business
    Table 41. Apotex Pharmachem Tofacitinib Citrate API Product and Services
    Table 42. Apotex Pharmachem Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Bulat Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 44. Bulat Pharmaceutical Major Business
    Table 45. Bulat Pharmaceutical Tofacitinib Citrate API Product and Services
    Table 46. Bulat Pharmaceutical Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. Delmar Chemicals Basic Information, Manufacturing Base and Competitors
    Table 48. Delmar Chemicals Major Business
    Table 49. Delmar Chemicals Tofacitinib Citrate API Product and Services
    Table 50. Delmar Chemicals Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 51. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 52. Glenmark Pharmaceuticals Major Business
    Table 53. Glenmark Pharmaceuticals Tofacitinib Citrate API Product and Services
    Table 54. Glenmark Pharmaceuticals Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 55. Kukjeon Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 56. Kukjeon Pharmaceutical Major Business
    Table 57. Kukjeon Pharmaceutical Tofacitinib Citrate API Product and Services
    Table 58. Kukjeon Pharmaceutical Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 59. MSN Laboratories Basic Information, Manufacturing Base and Competitors
    Table 60. MSN Laboratories Major Business
    Table 61. MSN Laboratories Tofacitinib Citrate API Product and Services
    Table 62. MSN Laboratories Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 63. Mylan Inc Basic Information, Manufacturing Base and Competitors
    Table 64. Mylan Inc Major Business
    Table 65. Mylan Inc Tofacitinib Citrate API Product and Services
    Table 66. Mylan Inc Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 67. Vitalpharms Basic Information, Manufacturing Base and Competitors
    Table 68. Vitalpharms Major Business
    Table 69. Vitalpharms Tofacitinib Citrate API Product and Services
    Table 70. Vitalpharms Tofacitinib Citrate API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 71. Global Tofacitinib Citrate API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
    Table 72. Global Tofacitinib Citrate API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 73. Market Position of Manufacturers in Tofacitinib Citrate API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 74. Global Tofacitinib Citrate API Production Capacity by Company, (Tons): 2020 VS 2021
    Table 75. Head Office and Tofacitinib Citrate API Production Site of Key Manufacturer
    Table 76. Tofacitinib Citrate API New Entrant and Capacity Expansion Plans
    Table 77. Tofacitinib Citrate API Mergers & Acquisitions in the Past Five Years
    Table 78. Global Tofacitinib Citrate API Sales by Region (2017-2022) & (Tons)
    Table 79. Global Tofacitinib Citrate API Sales by Region (2023-2028) & (Tons)
    Table 80. Global Tofacitinib Citrate API Revenue by Region (2017-2022) & (USD Million)
    Table 81. Global Tofacitinib Citrate API Revenue by Region (2023-2028) & (USD Million)
    Table 82. Global Tofacitinib Citrate API Sales by Purity (2017-2022) & (Tons)
    Table 83. Global Tofacitinib Citrate API Sales by Purity (2023-2028) & (Tons)
    Table 84. Global Tofacitinib Citrate API Revenue by Purity (2017-2022) & (USD Million)
    Table 85. Global Tofacitinib Citrate API Revenue by Purity (2023-2028) & (USD Million)
    Table 86. Global Tofacitinib Citrate API Price by Purity (2017-2022) & (US$/Kg)
    Table 87. Global Tofacitinib Citrate API Price by Purity (2023-2028) & (US$/Kg)
    Table 88. Global Tofacitinib Citrate API Sales by Application (2017-2022) & (Tons)
    Table 89. Global Tofacitinib Citrate API Sales by Application (2023-2028) & (Tons)
    Table 90. Global Tofacitinib Citrate API Revenue by Application (2017-2022) & (USD Million)
    Table 91. Global Tofacitinib Citrate API Revenue by Application (2023-2028) & (USD Million)
    Table 92. Global Tofacitinib Citrate API Price by Application (2017-2022) & (US$/Kg)
    Table 93. Global Tofacitinib Citrate API Price by Application (2023-2028) & (US$/Kg)
    Table 94. North America Tofacitinib Citrate API Sales by Country (2017-2022) & (Tons)
    Table 95. North America Tofacitinib Citrate API Sales by Country (2023-2028) & (Tons)
    Table 96. North America Tofacitinib Citrate API Revenue by Country (2017-2022) & (USD Million)
    Table 97. North America Tofacitinib Citrate API Revenue by Country (2023-2028) & (USD Million)
    Table 98. North America Tofacitinib Citrate API Sales by Purity (2017-2022) & (Tons)
    Table 99. North America Tofacitinib Citrate API Sales by Purity (2023-2028) & (Tons)
    Table 100. North America Tofacitinib Citrate API Sales by Application (2017-2022) & (Tons)
    Table 101. North America Tofacitinib Citrate API Sales by Application (2023-2028) & (Tons)
    Table 102. Europe Tofacitinib Citrate API Sales by Country (2017-2022) & (Tons)
    Table 103. Europe Tofacitinib Citrate API Sales by Country (2023-2028) & (Tons)
    Table 104. Europe Tofacitinib Citrate API Revenue by Country (2017-2022) & (USD Million)
    Table 105. Europe Tofacitinib Citrate API Revenue by Country (2023-2028) & (USD Million)
    Table 106. Europe Tofacitinib Citrate API Sales by Purity (2017-2022) & (Tons)
    Table 107. Europe Tofacitinib Citrate API Sales by Purity (2023-2028) & (Tons)
    Table 108. Europe Tofacitinib Citrate API Sales by Application (2017-2022) & (Tons)
    Table 109. Europe Tofacitinib Citrate API Sales by Application (2023-2028) & (Tons)
    Table 110. Asia-Pacific Tofacitinib Citrate API Sales by Region (2017-2022) & (Tons)
    Table 111. Asia-Pacific Tofacitinib Citrate API Sales by Region (2023-2028) & (Tons)
    Table 112. Asia-Pacific Tofacitinib Citrate API Revenue by Region (2017-2022) & (USD Million)
    Table 113. Asia-Pacific Tofacitinib Citrate API Revenue by Region (2023-2028) & (USD Million)
    Table 114. Asia-Pacific Tofacitinib Citrate API Sales by Purity (2017-2022) & (Tons)
    Table 115. Asia-Pacific Tofacitinib Citrate API Sales by Purity (2023-2028) & (Tons)
    Table 116. Asia-Pacific Tofacitinib Citrate API Sales by Application (2017-2022) & (Tons)
    Table 117. Asia-Pacific Tofacitinib Citrate API Sales by Application (2023-2028) & (Tons)
    Table 118. South America Tofacitinib Citrate API Sales by Country (2017-2022) & (Tons)
    Table 119. South America Tofacitinib Citrate API Sales by Country (2023-2028) & (Tons)
    Table 120. South America Tofacitinib Citrate API Revenue by Country (2017-2022) & (USD Million)
    Table 121. South America Tofacitinib Citrate API Revenue by Country (2023-2028) & (USD Million)
    Table 122. South America Tofacitinib Citrate API Sales by Purity (2017-2022) & (Tons)
    Table 123. South America Tofacitinib Citrate API Sales by Purity (2023-2028) & (Tons)
    Table 124. South America Tofacitinib Citrate API Sales by Application (2017-2022) & (Tons)
    Table 125. South America Tofacitinib Citrate API Sales by Application (2023-2028) & (Tons)
    Table 126. Middle East & Africa Tofacitinib Citrate API Sales by Region (2017-2022) & (Tons)
    Table 127. Middle East & Africa Tofacitinib Citrate API Sales by Region (2023-2028) & (Tons)
    Table 128. Middle East & Africa Tofacitinib Citrate API Revenue by Region (2017-2022) & (USD Million)
    Table 129. Middle East & Africa Tofacitinib Citrate API Revenue by Region (2023-2028) & (USD Million)
    Table 130. Middle East & Africa Tofacitinib Citrate API Sales by Purity (2017-2022) & (Tons)
    Table 131. Middle East & Africa Tofacitinib Citrate API Sales by Purity (2023-2028) & (Tons)
    Table 132. Middle East & Africa Tofacitinib Citrate API Sales by Application (2017-2022) & (Tons)
    Table 133. Middle East & Africa Tofacitinib Citrate API Sales by Application (2023-2028) & (Tons)
    Table 134. Tofacitinib Citrate API Raw Material
    Table 135. Key Manufacturers of Tofacitinib Citrate API Raw Materials
    Table 136. Direct Channel Pros & Cons
    Table 137. Indirect Channel Pros & Cons
    Table 138. Tofacitinib Citrate API Typical Distributors
    Table 139. Tofacitinib Citrate API Typical Customers
List of Figures
    Figure 1. Tofacitinib Citrate API Picture
    Figure 2. Global Tofacitinib Citrate API Revenue Market Share by Purity in 2021
    Figure 3. 0.98
    Figure 4. 0.99
    Figure 5. Others
    Figure 6. Global Tofacitinib Citrate API Revenue Market Share by Application in 2021
    Figure 7. Tablets
    Figure 8. Others
    Figure 9. Global Tofacitinib Citrate API Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
    Figure 10. Global Tofacitinib Citrate API Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Tofacitinib Citrate API Sales (2017-2028) & (Tons)
    Figure 12. Global Tofacitinib Citrate API Price (2017-2028) & (US$/Kg)
    Figure 13. Global Tofacitinib Citrate API Production Capacity (2017-2028) & (Tons)
    Figure 14. Global Tofacitinib Citrate API Production Capacity by Geographic Region: 2022 VS 2028
    Figure 15. Tofacitinib Citrate API Market Drivers
    Figure 16. Tofacitinib Citrate API Market Restraints
    Figure 17. Tofacitinib Citrate API Market Trends
    Figure 18. Global Tofacitinib Citrate API Sales Market Share by Manufacturer in 2021
    Figure 19. Global Tofacitinib Citrate API Revenue Market Share by Manufacturer in 2021
    Figure 20. Tofacitinib Citrate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 21. Top 3 Tofacitinib Citrate API Manufacturer (Revenue) Market Share in 2021
    Figure 22. Top 6 Tofacitinib Citrate API Manufacturer (Revenue) Market Share in 2021
    Figure 23. Global Tofacitinib Citrate API Sales Market Share by Region (2017-2028)
    Figure 24. Global Tofacitinib Citrate API Revenue Market Share by Region (2017-2028)
    Figure 25. North America Tofacitinib Citrate API Revenue (2017-2028) & (USD Million)
    Figure 26. Europe Tofacitinib Citrate API Revenue (2017-2028) & (USD Million)
    Figure 27. Asia-Pacific Tofacitinib Citrate API Revenue (2017-2028) & (USD Million)
    Figure 28. South America Tofacitinib Citrate API Revenue (2017-2028) & (USD Million)
    Figure 29. Middle East & Africa Tofacitinib Citrate API Revenue (2017-2028) & (USD Million)
    Figure 30. Global Tofacitinib Citrate API Sales Market Share by Purity (2017-2028)
    Figure 31. Global Tofacitinib Citrate API Revenue Market Share by Purity (2017-2028)
    Figure 32. Global Tofacitinib Citrate API Price by Purity (2017-2028) & (US$/Kg)
    Figure 33. Global Tofacitinib Citrate API Sales Market Share by Application (2017-2028)
    Figure 34. Global Tofacitinib Citrate API Revenue Market Share by Application (2017-2028)
    Figure 35. Global Tofacitinib Citrate API Price by Application (2017-2028) & (US$/Kg)
    Figure 36. North America Tofacitinib Citrate API Sales Market Share by Purity (2017-2028)
    Figure 37. North America Tofacitinib Citrate API Sales Market Share by Application (2017-2028)
    Figure 38. North America Tofacitinib Citrate API Sales Market Share by Country (2017-2028)
    Figure 39. North America Tofacitinib Citrate API Revenue Market Share by Country (2017-2028)
    Figure 40. United States Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Canada Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Mexico Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Europe Tofacitinib Citrate API Sales Market Share by Purity (2017-2028)
    Figure 44. Europe Tofacitinib Citrate API Sales Market Share by Application (2017-2028)
    Figure 45. Europe Tofacitinib Citrate API Sales Market Share by Country (2017-2028)
    Figure 46. Europe Tofacitinib Citrate API Revenue Market Share by Country (2017-2028)
    Figure 47. Germany Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. France Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. United Kingdom Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Russia Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Italy Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Asia-Pacific Tofacitinib Citrate API Sales Market Share by Region (2017-2028)
    Figure 53. Asia-Pacific Tofacitinib Citrate API Sales Market Share by Application (2017-2028)
    Figure 54. Asia-Pacific Tofacitinib Citrate API Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Tofacitinib Citrate API Revenue Market Share by Region (2017-2028)
    Figure 56. China Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Korea Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Tofacitinib Citrate API Sales Market Share by Purity (2017-2028)
    Figure 63. South America Tofacitinib Citrate API Sales Market Share by Application (2017-2028)
    Figure 64. South America Tofacitinib Citrate API Sales Market Share by Country (2017-2028)
    Figure 65. South America Tofacitinib Citrate API Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East & Africa Tofacitinib Citrate API Sales Market Share by Purity (2017-2028)
    Figure 69. Middle East & Africa Tofacitinib Citrate API Sales Market Share by Application (2017-2028)
    Figure 70. Middle East & Africa Tofacitinib Citrate API Sales Market Share by Region (2017-2028)
    Figure 71. Middle East & Africa Tofacitinib Citrate API Revenue Market Share by Region (2017-2028)
    Figure 72. Turkey Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Egypt Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Africa Tofacitinib Citrate API Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Manufacturing Cost Structure Analysis of Tofacitinib Citrate API in 2021
    Figure 77. Manufacturing Process Analysis of Tofacitinib Citrate API
    Figure 78. Tofacitinib Citrate API Industrial Chain
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Huateng Pharma
Beijing Mesochem Technology
CR Double-Crane Pharmaceuticals
Changzhou Pharmaceutical Factory
Chongqing Fuan Pharmaceutical
Sichuan Renan Pharmaceutical
Metrochem API
Dr. Reddy's Laboratories
Kekule Pharma
Apotex Pharmachem
Bulat Pharmaceutical
Delmar Chemicals
Glenmark Pharmaceuticals
Kukjeon Pharmaceutical
MSN Laboratories
Mylan Inc
Vitalpharms

Related Reports

Global Tofacitinib Citrate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Tofacitinib Citrate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Jan 2023

date Chemical & Material

According to our (Global Info Research) latest study, the global Tofacitinib Citrate API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Tofacitinib Citrate API Supply, Demand and Key Producers, 2023-2029

Global Tofacitinib Citrate API Supply, Demand and Key Producers, 2023-2029

date 13 Feb 2023

date Chemical & Material

The global Tofacitinib Citrate API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Tofacitinib Citrate API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Tofacitinib Citrate API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 12 Jan 2024

date Chemical & Material

According to our (Global Info Research) latest study, the global Tofacitinib Citrate API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

tofacitinib citrate api

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>